FIG 5.
DDIR/HRD provides a therapeutic vulnerability–based classification scheme in TNBC. DDIR, DNA damage immune response; HRD, homologous recombination deficiency; TNBC, triple-negative breast cancer. Figure created on BioRender.com.25
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.